Advertisement
Research Article

Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness

  • Els Torreele mail,

    e.torreele@gmail.com

    Affiliation: Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

    X
  • Bernadette Bourdin Trunz,

    Affiliation: Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

    X
  • David Tweats,

    Affiliations: Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland, The Medical School, University of Swansea, Swansea, United Kingdom

    X
  • Marcel Kaiser,

    Affiliations: Parasite Chemotherapy, Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

    X
  • Reto Brun,

    Affiliations: Parasite Chemotherapy, Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

    X
  • Guy Mazué,

    Affiliation: Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

    X
  • Michael A. Bray,

    Affiliation: Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

    X
  • Bernard Pécoul

    Affiliation: Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

    X

About the Authors

Els Torreele, Bernadette Bourdin Trunz, David Tweats, Guy Mazué, Michael A. Bray, Bernard Pécoul
Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
David Tweats
The Medical School, University of Swansea, Swansea, United Kingdom
Marcel Kaiser, Reto Brun
Parasite Chemotherapy, Swiss Tropical and Public Health Institute, Basel, Switzerland
Marcel Kaiser, Reto Brun
University of Basel, Basel, Switzerland

Corresponding Author

Email: e.torreele@gmail.com

Competing Interests

DT, GM and MAB are paid consultants to DNDi. All other authors declare that they have no competing interests.

Author Contributions

Conceived and designed the experiments: ET BBT DT MK RB GM MAB BP. Performed the experiments: BBT MK RB MAB. Analyzed the data: DT MK RB GM. Contributed reagents/materials/analysis tools: BBT. Wrote the paper: ET BBT MAB.